![]() |
Alpha 1 Antitrypsin Mutation |
Credits: 1.00 Post-Assessment Questions: 3
Release Date: 5 Oct 2020
Expiration Date: 15 Jul 2021
Last Reviewed: 15 Jul 2020
Estimated Time To Finish: 60 Minutes
Need Help? If you have a system or content concerns, please contact support@statpearls.com, or call (727) 289-9796.
Alpha-1 antitrypsin is a protease inhibitor produced primarily in the liver. It inhibits the neutrophil elastase activity in the lung and hence can protect it from proteolytic damage. It is responsible for approximately 90% of the protection against elastolytic activity in the lower airways caused by elastase released from neutrophils. If the neutrophils' elastases are not opposed, panacinar lung tissue is damaged and increases the risk of developing chronic obstructive pulmonary disease (COPD). On the other hand, the retention and accumulation of mutated polymers in the endoplasmic reticulum of hepatocytes renders the individuals with this disease at risk of "a gain of toxic function" leading to liver disease. This activity reviews the evaluation and management of alpha-1 antitrypsin mutation and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes in the care of patients with this rare condition.
This activity has been designed to meet the educational needs of physicians.
At the conclusion of this activity, the learner will be better able to:
Each author, editor, faculty and planning committee member have completed a disclosure form indicating that neither they nor their spouse/partner has a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content of this activity.
COMMERCIAL SUPPORT: This activity has received NO commercial support.
Hover over the contributor names to see details and disclosures of any financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.
Authors: Ali Abdulkarim
Editors: Timothy Craig
Editors-In-Chief: Truptesh KothariSilvio de Melo Jr.Vittorio Giuliano
Chief Medical Reviewer: Donna Aileen Trovela
Nurse Planner/Reviewer/Editor: Lisa Haddad
Nurse Planner/Reviewer/Editor: Bernadette Makar
Nurse Planner/Reviewer/Editor: Dorothy Caputo
Pharmacy Planner/Reviewer/Editor: Mark Pellegrini
Physician Planner/Reviewer/Editor: Scott Dulebohn
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Quillen College of Medicine, East Tennessee State University, and StatPearls, LLC. The Quillen College of Medicine, East Tennessee State University is accredited by the ACCME to provide continuing medical education for physicians.
Quillen College of Medicine, East Tennessee State University designates this activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.
Equal Opportunity
Medium or Media Used:
Instructions for Credit
StatPearls and ETSU adhere to ACCME Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and ETSU that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.
The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
The contributors and editors of StatPearls have attested that all associated media (images and video) have been legally cleared for use with this activity. All copyrights are reserved.
5 Star | |
4 Star | |
3 Star | |
2 Star | |
1 Star |
Stay up to date on the latest medical knowledge with 6047 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 6540.5 hours of CME.